AI assistant
MEDIFAST INC — Director's Dealing 2025
Mar 18, 2025
33899_dirs_2025-03-18_945160eb-dfe0-4529-9887-302b63e71146.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2025-03-13
Reporting Person: Chard Daniel R (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-13 | Common Stock | F | 5001 | $13.87 | Disposed | 54101 | Direct |
| 2025-03-16 | Common Stock | F | 944 | $13.94 | Disposed | 53157 | Direct |
| 2025-03-17 | Common Stock | F | 1864 | $14.35 | Disposed | 51293 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 149317.352 | Indirect |
Footnotes
F1: Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.
F2: These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.